Breakdown | |||||
TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
454.57B | 456.97B | 505.98B | 430.16B | 311.12B | 315.39B | Gross Profit |
4.05B | 42.32B | -157.00M | 32.71B | 22.79B | 20.06B | EBIT |
-13.01B | 24.42B | -15.01B | 18.12B | 10.54B | 7.01B | EBITDA |
-1.54B | 36.88B | -2.03B | 21.34B | -5.29B | 10.33B | Net Income Common Stockholders |
-10.62B | 26.99B | -15.83B | 15.19B | -12.63B | 7.99B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
160.66B | 307.28B | 102.07B | 61.24B | 68.80B | 106.99B | Total Assets |
445.65B | 461.03B | 426.97B | 406.59B | 395.40B | 329.58B | Total Debt |
23.60B | 23.60B | 23.60B | 29.09B | 45.62B | 45.75B | Net Debt |
-137.06B | -129.74B | -78.47B | -32.15B | -23.17B | -61.24B | Total Liabilities |
418.59B | 435.57B | 420.89B | 384.28B | 379.64B | 292.84B | Stockholders Equity |
25.21B | 23.71B | 4.86B | 22.18B | 15.65B | 36.40B |
Cash Flow | Free Cash Flow | ||||
0.00 | 55.97B | 58.86B | 41.37B | -27.73B | -22.95B | Operating Cash Flow |
0.00 | 57.66B | 62.75B | 44.16B | -25.59B | -20.81B | Investing Cash Flow |
0.00 | -4.18B | -1.57B | 7.89B | -3.79B | -2.25B | Financing Cash Flow |
0.00 | -298.00M | -5.85B | -17.06B | -4.20B | 9.48B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
70 Outperform | $88.05B | 3.26 | 186.66% | ― | -9.69% | ― | |
66 Neutral | $4.47B | 12.22 | 5.40% | 3.65% | 4.14% | -12.00% | |
$2.21B | ― | -0.17% | 0.02% | ― | ― | ||
84 Outperform | ¥82.90B | 10.09 | 5.64% | 4.90% | 62.07% | ||
82 Outperform | ¥67.07B | 8.17 | 3.64% | 9.78% | 38.18% | ||
73 Outperform | ¥79.53B | 13.30 | 2.84% | 7.19% | 24.96% | ||
63 Neutral | ¥87.20B | 15.26 | 2.90% | 10.88% | -29.60% |